Friday, January 30, 2026

Bill Gates Reveals He Uses Samsung Phone Gifted by Chairman Lee Jae-yong

Bill Gates shares insights on philanthropy and reveals his Samsung phone gift from Lee Jae-yong in an upcoming tvN interview.

North Korea Ignores South Korea-China Summit… To Forge Ahead Until Party Congress

The government plans a meeting to discuss North Korean issues and establish a consultation channel with the U.S. Embassy.

Moon Mining Starts Underground—South Korea Tests Space Tech in Coal Shafts

KIGAM is testing lunar exploration technologies, aiming for resource development and collaboration with NASA's Artemis program.

Dae Hyun Moon

Samsung Biologics Earns EcoVadis Platinum: What Joining the Top 1% Signals for Global Pharma Supply Chains

Samsung Biologics achieves Platinum rating from EcoVadis, recognizing its top-tier ESG performance in sustainability and corporate responsibility.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

How EverEx’s AI Solutions Are Transforming Musculoskeletal Care in the U.S. Market

EverEx is revolutionizing remote therapy monitoring in the U.S. with AI technology, aiming for a fivefold sales increase this year.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

Revolutionizing Regenerative Medicine: Rokit Healthcare’s AI Partnership with the UAE’s Leading Healthcare Firm

Rokit Healthcare partners with UAE's largest healthcare firm to expand its AI-driven regenerative medicine in the Middle East and globally.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

Latest Neonatal Resuscitation Guidelines: Key Insights for Healthcare Professionals

GE Healthcare Korea held a webinar on neonatal resuscitation guidelines to enhance perinatal care and improve treatment outcomes.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

JLK’s Stroke AI Goes Subscription-Based as University Hospitals Drive Adoption

JLK's stroke AI solution enhances diagnosis and treatment at Chung-Ang University Hospital, improving patient care and revenue growth.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us